Fuclav Tablet 250 mg+62.5 mg is a potent combination antibiotic containing Cefuroxime Axetil and Clavulanic Acid, designed to treat a broad range of bacterial infections. Cefuroxime Axetil is a second-generation cephalosporin that works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid is a beta-lactamase inhibitor that prevents the breakdown of cefuroxime by beta-lactamase-producing bacteria, enhancing its effectiveness against resistant strains.

This combination ensures broad-spectrum antibacterial activity, making Fuclav 250 mg+62.5 mg suitable for moderate to severe infections caused by Gram-positive and Gram-negative bacteria. The oral tablet formulation allows for convenient dosing, making it suitable for both adult and pediatric patients under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Fuclav Tablet 250 mg+62.5 mg is indicated for the treatment of:

• Respiratory tract infections such as sinusitis, bronchitis, and pneumonia

• Ear, nose, and throat infections including otitis media, tonsillitis, and pharyngitis

• Skin and soft tissue infections, including cellulitis, abscesses, and wound infections

• Urinary tract infections caused by susceptible bacteria

• Surgical prophylaxis to prevent postoperative infections

• Other infections caused by beta-lactamase-producing bacteria

The combination is effective against common pathogens such as Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and other Gram-negative organisms.

Dosage and Administration

The dosage of Fuclav Tablet 250 mg+62.5 mg depends on infection severity, age, and body weight:

• Adults: Usually one tablet every 8–12 hours or as directed by a physician

• Pediatric patients: Dose calculated based on body weight and infection severity

• Take the tablet orally with water; it may be taken with or without food

• Maintain regular dosing intervals for optimum therapeutic effect

• Complete the full course of therapy even if symptoms improve early to prevent recurrence and bacterial resistance

Benefits

• Broad-spectrum antibacterial activity effective against Gram-positive and Gram-negative bacteria

• Beta-lactamase inhibition enhances efficacy against resistant strains

• Suitable for moderate to severe infections of the respiratory tract, ENT, skin, and urinary system

• Convenient oral tablet for outpatient treatment

• Helps prevent complications by effectively eradicating infection

Side Effects

Fuclav Tablet 250 mg+62.5 mg is generally well tolerated. Common mild side effects include:

• Nausea, vomiting, or diarrhea

• Abdominal discomfort or bloating

• Rash, itching, or mild allergic reactions

• Headache or dizziness

Rare but serious side effects may include: severe allergic reactions, liver toxicity, or Clostridium difficile-associated diarrhea. Immediate medical attention is required if severe rash, swelling, difficulty breathing, or persistent diarrhea occurs.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Avoid in patients with known hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics

• Use with caution in patients with kidney or liver impairment; dose adjustment may be necessary

• Inform the physician of all medications to prevent drug interactions

• Pregnant and breastfeeding women should use only under medical supervision

• Monitor for signs of superinfection during prolonged therapy

Storage

Store below 30°C in a dry, light-protected place. Keep out of reach of children. Ensure the container is tightly closed after use to maintain efficacy.

Fuclav Tablet 250 mg+62.5 mg (Cefuroxime Axetil + Clavulanic Acid) is a reliable oral antibiotic for moderate to severe bacterial infections. Its broad-spectrum activity, combined with beta-lactamase protection, ensures effective treatment and faster recovery under proper medical supervision.